SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0000950157-19-001296
Filing Date
2019-11-12
Accepted
2019-11-12 09:19:12
Documents
4
Group Members
DRAGONFLY ACQUISITION CORP.DRAGONFLY HOLDING CORP.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 sctota.htm SC TO-T/A 35450
2 PRESS RELEASE ex99a5d.htm EX-99.(A)(5)(D) 12534
3 PRESS RELEASE ex99a5e.htm EX-99.(A)(5)(E) 8497
4 image1.jpg GRAPHIC 3898
  Complete submission text file 0000950157-19-001296.txt   63706
Mailing Address 240 LEIGH FARM ROAD DURHAM NC 27707
Business Address 240 LEIGH FARM ROAD DURHAM NC 27707 919-806-4487
Dova Pharmaceuticals Inc. (Subject) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-90057 | Film No.: 191206559
SIC: 2834 Pharmaceutical Preparations

Mailing Address TOMTEBODAVAGEN 23A STOCKHOLM V7 SE-112 76
Business Address TOMTEBODAVAGEN 23A STOCKHOLM V7 SE-112 76 46 8 697 20 00
Swedish Orphan Biovitrum AB (publ) (Filed by) CIK: 0001789731 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC TO-T/A